title: Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
abstract: BACKGROUND
  The recent focus on the development of preventive interventions for Alzheimer disease has fueled the search for biomarkers of presymptomatic disease. Patients with Alzheimer disease and mild cognitive impairment have marked atrophy of the hippocampus and amygdala compared with healthy elderly people. Whether atrophy of these structures is also present in persons without cognitive impairment who later develop dementia is unknown.
  
  
  OBJECTIVE
  To assess whether volumetric assessment of the hippocampus and amygdala using magnetic resonance imaging (MRI) predicts dementia in elderly people without cognitive impairment.
  
  
  METHODS
  Longitudinal cohort study.
  
  
  METHODS
  A general community in the Netherlands.
  
  
  METHODS
  Five hundred eleven persons, aged 60 to 90 years, free of dementia at baseline were followed up during 3043 person-years (mean per person, 6.0 years). We performed volumetric assessment of the hippocampus and amygdala, obtained information about daily memory problems, and performed extensive neuropsychological testing in all study participants.
  
  
  METHODS
  Dementia, as assessed by repeated neuropsychological screening and monitoring of medical records.
  
  
  RESULTS
  Thirty-five persons developed dementia (26 with Alzheimer disease). Hippocampal and amygdalar volumes were strongly associated with the risk of dementia; the age-, sex-, and education-adjusted hazard ratio per 1-SD decrease in volume was 3.0 (95% confidence interval, 2.0-4.6) for the hippocampus and 2.1 (95% confidence interval, 1.5-2.9) for the amygdala. The hazard ratios associated with atrophy were similar in persons without memory complaints or low cognitive function at baseline. Compared with those remaining free of dementia, baseline brain volumes were 17% smaller in persons who received a clinical diagnosis of dementia within 2 to 3 years after MRI and still 5% smaller in those whose conditions were diagnosed 6 years after MRI.
  
  
  CONCLUSIONS
  Atrophy of the hippocampus and amygdala on MRI in cognitively intact elderly people predicts dementia during a 6-year follow-up.
authors.affiliation: Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, the Netherlands.
authors.forename: Tom
authors.initials: T
authors.lastname: den Heijer
authors.forename: Mirjam I
authors.initials: MI
authors.lastname: Geerlings
authors.forename: Freek E
authors.initials: FE
authors.lastname: Hoebeek
authors.forename: Albert
authors.initials: A
authors.lastname: Hofman
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Koudstaal
authors.forename: Monique M B
authors.initials: MM
authors.lastname: Breteler
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis / Q000473:pathology / Q000523:psychology; D000679:Amygdala / Q000473:pathology*; D001284:Atrophy; D015415:Biomarkers; D002544:Cerebral Infarction / Q000175:diagnosis / Q000473:pathology; D003071:Cognition; D003072:Cognition Disorders / Q000175:diagnosis / Q000473:pathology; D015331:Cohort Studies; D003704:Dementia / Q000175:diagnosis / Q000473:pathology* / Q000523:psychology*; D005260:Female; D005500:Follow-Up Studies; D006624:Hippocampus / Q000473:pathology*; D006801:Humans; D008137:Longitudinal Studies; D008279:Magnetic Resonance Imaging / Q000706:statistics & numerical data*; D008297:Male; D009483:Neuropsychological Tests; D011379:Prognosis; D011569:Psychiatric Status Rating Scales; D011597:Psychomotor Performance; D012307:Risk Factors
chemical_list: D015415:Biomarkers